Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs ; volume:40 ; number:3 ; day:24 ; month:2 ; year:2023 ; pages:661-674 ; date:3.2023
Pharmaceutical research ; 40, Heft 3 (24.2.2023), 661-674, 3.2023
- Urheber
-
Pardridge, William M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-023-03484-2
- URN
-
urn:nbn:de:101:1-2023081121182672165902
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pardridge, William M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat